Hepatocarcinogenesis by peroxisome proliferators

Journal of Toxicological Sciences

Volumn 29, Issue 1, 2004, Pages 1-12

  Suga, Tetsuya ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Hepatocarcinogenesis; Hepatocyte growth factor (HGF); Nongenotoxic carcinogenesis; Peroxisome proliferator (PP); Peroxisome proliferator activated receptor (PPAR); Wy 14,643

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; GENOTOXICITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRECANCER; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVIEW; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALIA; RODENTIA;

EID: 1642504403     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.29.1     Document Type: Review

References (36)

1. Blaauboer, B.J., Holsteijn, C.W.M., Bleumink, R., Mennes, W.C., Pelt, F.N.A.M., Yap, S.H., Pelt, J.F., Iersel, A.A.J., Timmerman, A. and Schmid, B.P. (1990): The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem. Pharmacol., 40, 521-528.
2. Cohen, A.J. and Grasso, P. (1981): Review of the hepatic response to hyopolipidemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet. Toxicol., 19, 585-605.
3. Eacho, P.I., Foxworthy, P.S., Johnson, W.D., Hoover, D.M. and White, S.L. (1986): Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol. Appl. Pharmacol., 83, 430-437.
4. Escher, P. and Wahli, W. (2000): Peroxisome proliferator-activated receptors: Onsight into multiple cellular functions. Mutat. Res., 448. 121-138.
5. Foxworthy, P.S., White, S.L., Hoover, D.M. and Eacho, P.I. (1990): Effect of ciprofibrate, bezafibrate and LY-171,883 on peroxisomal β-oxidation in cultured rat, dog and rhesus monkey hepatocytes. Toxicol. Appl. Pharmacol., 104, 386-394.
6. Gonzalez, F.J., Peters, J.M. and Cattley, R.C. (1998): Mechanism of action of the nongenotoxic peroxisome proiferators: Role of the peroxisome proliferator-activated receptor α. J. Natl. Cancer Inst., 90, 1702-1709.
7. Gray, H.G. and de la Iglesia, F.A. (1984): Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species. Hepatology, 4, 520-530.
8. Hayashi, F., Motoki, Y., Tamura, H., Watanabe, T., Ogura, T., Esumi, H. and Suga, T. (1998): Induction of hepatic poly (ADP-ribose) polymerase by peroxisome proliferators, non-genotoxic hepatocarcinogens. Cancer Lett., 127, 1-7.
9. Hayashi, F., Tamura, H., Yamada, J., Kasai, H. and Suga, T. (1994): Characteristics of The hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis, 15, 2215-2219.
10. Hayashi, F., Tamura, H., Watanabe, T. and Suga, T. (1995): Enhancement by Peroxisome proliferators of the susceptibility to DNA damage in the liver of male F-344 rats. Cancer Lett., 92, 87-90.
11. Horie, S. and Suga, T. (1985): Enhancement of peroxisomal β-oxidation in the liver of rats and mice treated with valproic acid. Biochem. Pharmacol., 34, 1357-1362.
12. Ikeda, T., Fukuda, K. Mori, I. Enomoto, M., Komai, T. and Suga, T. (1987): Induction of cytochrome P-450 and peroxisome proliferation in rat liver by perfluorinated octane sulphonic acid (PFOS). In Peroxisomes Biol.Med. (Fahimi, H.D. and Sies, H., eds.), pp. 304-308, Springer-Verlag Berlin Heidelberg.
13. Ikeda, T., Ida-Enomoto, M., Mori, I., Fukuda, K., Iwabuchi, H., Komai, T. and Suga, T. (1988): Induction of peroxisome proliferation in rat liver by dietary treatment with 2,2,4,4,6,8,8-heptamethylnonane. Xenobiotica, 18, 1271-1280.
14. Ishii, H. and Suga, T. (1979): Clofibrate-like effects of acetylsalycylic acid on peroxisomes and on hepatic and serum triglyceride levels. Biochem. Pharmacol., 28, 2829-2833.
15. Issemann, I. and Green, S. (1990): Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
16. Kozuka, H., Yamada, J., Horie, S., Watanabe, T., Suga, T. and Ikeda, T. (1991): Characteristics of induction of peroxisomal fatty acid oxidation-related enzymes in rat liver by drugs: Relationships between structure and inducing activity. Biochem. Pharmacol., 41, 617-623.
17. Momose, Y., Shibata, N., Kiyosawa, I., Naito, J., Watanabe, T., Horie, S., Yamada, J., Suga, T. and Nagata, T. (1993): Morphometric evaluation of species differences in the effects of bezafibrate, a hypolipemic agent, on hepatic peroxisomes and mitochondria. J. Toxicol. Pathol., 6, 33-45.
18. Motoki, Y., Tamura, H., Morita, R., Watanabe, T. and Suga, T. (1997): Decreased hepatocyte growth factor level by Wy-14,643, non-genotoxic hepatocarcinogen, in F-344 rats. Carcinogenesis, 18, 1303-1309.
19. Motoki, Y., Tamura, H., Watanabe, T. and Suga, T. (1999): Wy-14,643, a peroxisome proliferator, inhibits compensative cell proliferation and hepatocyte growth factor mRNA expression in the rat liver. Cancer Lett., 135, 145-150.
20. Peters, J.M., Cattley, R.C. and Gonzalez, F.J. (1997): Role of PPARα in the mechanism of action of the non-genotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis, 18, 2029-2033.
21. Reddy, J.K., Lalwani, N.D., Qureshi, S.A., Reddy, M.K. and Moehle, C.M. (1984): Induction of hepatic peroxisome proliferation in non-rodent species including primates. Am. J. Pathol., 114, 171-183.
22. Reddy, J.K. and Rao, M.S. (1986): Peroxisome proliferators and cancer: Mechanism and Implications. Trends Pharmacol., 7, 438-443.
23. Sato, K. (1989): Glutathione transferases as markers of preneoplasia and neoplasia. Adv. Cancer Res., 52, 205-255.
24. Suga, T., Motoki, Y., Tamura, H. and Watanabe, T. (2000): Involvement of hepatocyte growth factor on hepatocarcinogenesis induced by peroxisome proliferators. Cell Biochem. Biophys., 32, 221-228.
25. Suga, T., Tamura, H., Watanabe, T. and Yamada, J. (1996): Induction of peroxisomal enzymes by dehydroepiandrosterone: Metabolic activation by sulfate conjugation. Ann. N. Y. Acad. Sci., 804, 284-296.
26. Tamura, H., Iida, T., Watanabe, T. and Suga, T. (1990a): Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and -scavenging capacities in the liver of Fischer-344 rats. Toxicology, 63, 199-213.
27. Tamura, H., Iida, T., Watanabe, T. and Suga, T. (1990b): Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Carcinogenesis, 11, 445-450.
28. Tamura, H., Iida, T., Watanabe, T. and Suga, T. (1991): Lack of induction of hepatic DNA damage on long-term administration of peroxisome proliferators in male F-344 rats. Toxicology, 69, 55-62.
29. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992): The mouse peroxisome proliferator-activated receptor recognizes a response element in the 5'-flanking sequence of the rat acyl-CoA oxidase gene. EMBO J., 11, 433-439.
30. Watanabe, T., Horie, S., Yamada, J., Isaji, M., Nishigaki, T., Naito, J. and Suga, T. (1984): Species difference of peroxisome proliferation in hepatocytes by bezafibrate. Clinical Report, 33, 4367-4377.
31. Watanabe, T., Horie, S., Yamada, J., Isaji, M., Nishigaki, T., Naito, J. and Suga, T. (1989): Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes. Biochem. Pharmacol., 38, 367-371.
32. Watanabe, T., Mitsukawa, M., Horie, S., Suga, T. and Seki, K. (1987): Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: Comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate. J. Pharmacobio-Dyn., 10, 142-147.
33. Watanabe, T. and Suga, T. (1985): Effects of some anti-inflammatory drugs on biochemical values and on hepatic peroxisomal enzymes of rat. J. Pharmacobio- Dyn., 8, 1060-1067.
34. 2 synthetase. J. Pharmacobio-Dyn., 9, 1023-1031.
35. Yamada, J., Sakuma, M., Ikeda, T., Fukuda, K. and Suga, T. (1991): Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta, 1092, 233-243.
36. Yokoyama, Y., Tsuchida, S., Hatayama, I., Sato, K., Narita, T., Rao, M.S., Reddy, J.K., Yamada, J., Suga, T. and Sato, K. (1992): Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers. Carcinogenesis, 13, 265-269.